Literature DB >> 10849899

Synthesis and diversity analysis of lead discovery piperazine-2-carboxamide libraries.

T F Herpin1, G C Morton, A K Dunn, C Fillon, P R Menard, S Y Tang, J M Salvino, R F Labaudinière.   

Abstract

A Lead Discovery Library of piperazine-2-carboxamide derivatives was produced for general screening. This paper discloses two novel solid phase synthetic routes used to produce 15,000 single compounds via the Irori directed sorting technique. Computational methods such as reagent clustering and library profiling were used to maximize reagent diversity and optimize pharmacokinetic parameters. The results of a four center pharmacophore analysis revealed the added diversity gained by using two independent synthetic routes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10849899     DOI: 10.1023/a:1009637817478

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  4 in total

Review 1.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.

Authors:  C A Lipinski; F Lombardo; B W Dominy; P J Feeney
Journal:  Adv Drug Deliv Rev       Date:  2001-03-01       Impact factor: 15.470

2.  The "One-Bead-One-Compound" Combinatorial Library Method.

Authors:  Kit S. Lam; Michal Lebl; Viktor Krchnák
Journal:  Chem Rev       Date:  1997-04-01       Impact factor: 60.622

3.  L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor.

Authors:  J P Vacca; B D Dorsey; W A Schleif; R B Levin; S L McDaniel; P L Darke; J Zugay; J C Quintero; O M Blahy; E Roth
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

4.  Evaluation of a structure-based statine cyclic diamino amide encoded combinatorial library against plasmepsin II and cathepsin D.

Authors:  C D Carroll; T O Johnson; S Tao; G Lauri; M Orlowski; I Y Gluzman; D E Goldberg; R E Dolle
Journal:  Bioorg Med Chem Lett       Date:  1998-11-17       Impact factor: 2.823

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.